Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Pramoxine is a local anesthetic.1 It reduces electrically induced peak compound action potential (CAP) amplitudes in isolated frog sciatic nerve (IC50 = 0.21 mM).2 Topical administration of pramoxine (0.35 and 0.6%) inhibits winking in a rabbit corneal test, indicating anesthetic activity.1 It inhibits the pinprick-induced cutaneous trunci muscle reflex (CTMR) in the skin of rats (ED50 = 42.1 μmol, s.c.).3
WARNING This product is not for human or veterinary use.
1. The pharmacology of pramoxine hydrochloride: A new topical local anesthetic. Curr. Res. Anesth. Analg. 32(6:1), 418-425 (1953).
2. Compound action potential inhibition produced by various antidepressants in the frog sciatic nerve. Eur. J. Pharmacol. 819, 122-128 (2018).
3. Skin nociceptive block with pramoxine delivery by subcutaneous injection in rats. Pharmacol. Rep. 70(6), 1180-1184 (2018).